Next Quarterly Earnings
Date confirmed from the official Chinese exchange disclosure timetable.
Hangzhou Tigermed Consulting is a leading global Contract Research Organization (CRO). The company supports the healthcare industry with full-service solutions in clinical development, regulatory affairs, and biostatistical analysis, helping to accelerate the delivery of medical innovations.
Date confirmed from the official Chinese exchange disclosure timetable.
Hangzhou Tigermed Consulting A is scheduled to report its next quarterly earnings on 08/29/2026.
Hangzhou Tigermed Consulting A last reported quarterly earnings on 4/28/2026 (Q1 2026). Earnings per share (EPS) came in at 0.06 CNY.
Across its last 3 earnings reports, Hangzhou Tigermed Consulting A stock moved by ±1.5% on average the following day. The largest reaction was +2.7% on 04/28/2026; 2 of 3 reactions were positive.
Hangzhou Tigermed Consulting A has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.